5-amino-1MQ peptide dosage per day is not officially established; here's what rodent studies and anecdotal human reports suggest, plus safety notes.
There is no clinically established 5-amino-1MQ peptide dosage per day for humans. In published rodent research, the compound has typically been given orally at roughly 2.5 to 5 mg/kg per day, while anecdotal human reports posted online often cite 50 to 150 mg per day. 5-amino-1MQ is not FDA-approved for human use, and no human trial has defined a safe or effective daily amount.
What 5-Amino-1MQ Actually Is
Despite the nickname, 5-amino-1MQ is a small synthetic molecule, not a true peptide. Its chemical name is 5-amino-1-methylquinolinium, and it works as an inhibitor of an enzyme called nicotinamide N-methyltransferase (NNMT).
- Class: small-molecule NNMT inhibitor, frequently sold alongside research peptides.
- Studied for: metabolic rate, fat cell behavior, and glucose handling in animal and cell models.
- Sold as: a research chemical, usually with a "not for human consumption" label.
Because it is a small molecule rather than a peptide chain, it survives digestion far better than most peptides. That single fact explains why most discussion centers on oral use rather than injections.
Why No Official Human Dose Exists
Published research on 5-amino-1MQ has been conducted in rodents and cultured cells, not in people. That means no dose-finding studies, no pharmacokinetic data in humans, and no established safety ceiling.
Without human data, any number you see online is an extrapolation or a personal experiment. Animal doses are usually scaled by body weight, and simple milligram-per-kilogram math does not translate cleanly from mice to humans.
Key point: a mouse dose of 2.5 to 5 mg/kg per day is not a human recommendation. It is a research reference point.
Reported Dosing Ranges in Research and Anecdotal Reports
The table below separates peer-reviewed animal data from internet anecdotes, because the two are not comparable in reliability.
| Setting | Route | Reported amount | Evidence quality |
|---|---|---|---|
| Rodent studies | Oral (diet or gavage) | About 2.5–5 mg/kg per day | Peer-reviewed animal data |
| Anecdotal human reports | Oral capsule or liquid | 50–150 mg per day, often split into 2 doses | Anecdotal only |
| Anecdotal human reports | Subcutaneous injection | Highly variable; no standard figure | Anecdotal only |
| Human clinical trials | Any | None established | No published human trials |
Most people who post about 5 amino 1mq peptide dosage describe starting low, holding for one to two weeks, and adjusting based on how they feel. That approach is self-experimentation, not evidence-based medicine.
Oral vs. Injectable and Subcutaneous Use
Nearly all research and community use of 5-amino-1MQ is oral. The compound is small enough to be absorbed through the gut, which is unusual for peptide-adjacent products.
Injectable versions do circulate, and people searching for a 5-amino-1mq injection dosage per day usually end up comparing it with oral protocols. There is no validated 5-amino-1mq subq dosage per day either, and injecting a research chemical adds risks such as contamination, dosing errors, and injection-site reactions.
- Oral: the route used in animal studies and the most commonly reported human route.
- Subcutaneous: reported anecdotally, with no pharmacokinetic basis for a specific number.
- Reconstitution: if a product requires mixing, math errors are common and can multiply the intended dose several times over.
Does Sex, Weight, or Age Change the Dose?
No human study has compared dosing by sex, body weight, or age. Any 5-amino-1mq dosage per day female users might follow is borrowed from male anecdotes, and women are often advised online to start lower — advice that has no clinical backing in either direction.
Body composition can change how fat-soluble and water-soluble drugs distribute, and liver and kidney function affect clearance. Those variables matter more than a number copied from a forum thread.
How 5-Amino-1MQ Compares With Other Peptides
People researching 5-amino-1MQ often look at other compounds at the same time. The table below reflects commonly cited research or anecdotal figures, not approved dosing.
| Compound | Commonly cited daily amount | Typical route | FDA-approved for human use? |
|---|---|---|---|
| 5-amino-1MQ | 50–150 mg (anecdotal) | Oral | No |
| Ipamorelin | 200–300 mcg (anecdotal) | Subcutaneous | No |
| GHK-Cu | 1–2 mg (anecdotal) | Subcutaneous or topical | No |
| IGF-1 LR3 | 20–50 mcg (anecdotal) | Subcutaneous | No |
These compounds work through completely different pathways, so the numbers are not interchangeable. Someone reviewing ipamorelin peptide dosage per day, for example, is looking at a growth hormone secretagogue, not an NNMT inhibitor. The same caution applies to IGF-1 LR3 dosage per day, where micrograms — not milligrams — are the relevant unit.
Safety, Side Effects, and Legal Status
5-amino-1MQ is not FDA-approved for human use in the United States. It is sold as a research chemical, which means it is not held to pharmaceutical standards for purity, potency, or labeling.
Reported side effects from anecdotal use include headaches, jitteriness, digestive upset, and changes in appetite or sleep. These reports are unverified. Because NNMT is involved in cellular metabolism and methylation chemistry, long-term effects on the liver or nervous system are unknown.
- Purity varies widely between vendors, and third-party certificates of analysis are not always genuine.
- Interactions with prescription drugs, including stimulants and diabetes medications, have not been studied.
- Anyone considering 5-amino-1MQ should talk with a licensed healthcare professional first.
The Bottom Line
No proven daily dose of 5-amino-1MQ exists for humans, and the numbers circulating online are estimates built on animal data and personal reports. If you are weighing it against a prescribed option, bring the question to a clinician rather than relying on a forum protocol.
Frequently Asked Questions
Is 5-amino-1MQ FDA approved?
No. 5-amino-1MQ is not FDA-approved for human use in the United States and is sold as a research chemical labeled "not for human consumption." That means it is not reviewed for purity, dosing accuracy, or safety in people. Any product marketed for human consumption is being sold outside its legal labeling.
How much 5-amino-1MQ do people take per day?
Anecdotal reports usually describe 50 to 150 mg per day, often split into two doses, while published rodent studies used roughly 2.5 to 5 mg/kg per day. There is no human clinical trial that establishes a safe or effective amount. These figures are not medical recommendations.
Can 5-amino-1MQ be taken orally?
Yes, oral use is the most commonly reported route because 5-amino-1MQ is a small molecule that can survive digestion better than most peptides. Nearly all published animal research also used oral administration. Injectable and subcutaneous versions circulate online, but no pharmacokinetic data supports a standard injected dose.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.